This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| International Conference on Pulmonary Diseases | |
|---|---|
| Name | International Conference on Pulmonary Diseases |
| Status | Active |
| Genre | Medical conference |
| Frequency | Annual / Biennial |
| Location | Rotating international venues |
| First | 20th century |
| Organizer | Consortium of respiratory societies |
| Website | Official website |
International Conference on Pulmonary Diseases is a recurring global forum dedicated to advances in pulmonary medicine, respiratory research, and clinical practice. The conference convenes clinicians, researchers, public health officials, industry representatives, and patient advocacy organizations to exchange findings on pulmonary infections, chronic obstructive pulmonary disease, asthma, interstitial lung disease, and critical care. Attendees typically include delegates from major medical institutions, national academies, and international agencies.
The conference traces its origins to national and regional meetings such as the American Thoracic Society seasonal assemblies and the early 20th-century congresses that brought together delegates from Royal Society of Medicine, Institut Pasteur, and the European Respiratory Society precursor gatherings. Post-World War II momentum from institutions like the World Health Organization and the National Institutes of Health catalyzed multinational conferences, informed by landmark studies from Johns Hopkins Hospital, Mayo Clinic, and Guy's Hospital. Landmark moments included collaborative sessions influenced by trials at Massachusetts General Hospital and translational initiatives linked to Imperial College London and Karolinska Institutet. Over subsequent decades the conference incorporated contributions from clinicians affiliated with Cleveland Clinic, Mount Sinai Health System, University of California, San Francisco, and University College London.
Primary objectives encompass dissemination of clinical trial results, fostering collaborations among centers such as Stanford School of Medicine and Harvard Medical School, and promoting guideline development with stakeholders like European Centre for Disease Prevention and Control and Centers for Disease Control and Prevention. Recurring themes include management of Chronic obstructive pulmonary disease (COPD) as studied at McMaster University, innovations in bronchoscopic techniques advanced at Karolinska University Hospital, and global tuberculosis control strategies aligned with Stop TB Partnership research. Other themes reflect contributions from specialty organizations including American College of Chest Physicians, Royal Brompton Hospital, and research networks associated with Mount Sinai Hospital.
Governance typically comprises steering committees representing the European Respiratory Society, American Thoracic Society, and national respiratory societies such as Japanese Respiratory Society and Indian Chest Society. Executive boards include representatives from academic centers like University of Toronto, Oxford University Hospitals, and University of Sydney. Scientific advisory panels recruit editors from journals including The Lancet, New England Journal of Medicine, and Thorax to ensure methodological rigor. Partnerships often involve international agencies such as the World Health Organization and philanthropic funders like the Bill & Melinda Gates Foundation.
Notable meetings have been held in global hubs: sessions hosted in Geneva featured collaboration with World Health Organization leadership; programs in Boston aligned with local research from Brigham and Women's Hospital; editions in Tokyo highlighted innovations from Keio University and University of Tokyo; meetings in London engaged clinicians from Royal Free Hospital and Guy's and St Thomas' NHS Foundation Trust. Special symposia have paired with events such as the World Congress of Cardiology and the International AIDS Conference to address comorbidities and coinfections documented by investigators at University of Cape Town and University of São Paulo.
The scientific program integrates plenary lectures by investigators from institutions like Dana-Farber Cancer Institute and Scripps Research, oral presentation sessions featuring multicenter trials coordinated by NIH Clinical Center, and poster sessions showcasing work from universities such as Peking University and Seoul National University. Session tracks commonly include translational research informed by laboratories at Francis Crick Institute, clinical pharmacology updates referencing trials at GlaxoSmithKline and AstraZeneca, and respiratory imaging advances connected to teams from Mayo Clinic radiology and Karolinska Institutet imaging units.
Proceedings and consensus statements often appear in journals including The Lancet Respiratory Medicine, Chest (journal), and European Respiratory Journal with participation from editorial boards of BMJ and JAMA. The conference has contributed to clinical practice guidelines developed in partnership with organizations such as the American Thoracic Society and European Respiratory Society, echoing methodologies used by the National Institute for Health and Care Excellence and guideline panels affiliated with Cochrane Collaboration.
The conference has influenced policy and practice through dissemination of pivotal trial results from centers like Vanderbilt University Medical Center and University of Pennsylvania, accelerated adoption of pulmonary rehabilitation programs modeled on initiatives at University of British Columbia, and fostered global research networks linking Institut Pasteur and Centers for Disease Control and Prevention. Collaborative outputs have addressed burden of disease in regions represented by World Bank health programs and informed vaccine strategies discussed with the Gavi, the Vaccine Alliance.
Attendees typically include investigators from academic centers such as Yale School of Medicine, clinicians from hospital systems like UCLA Health, representatives of governmental agencies including National Institutes of Health and Public Health England, and industry delegates from biotechnology firms clustered in Cambridge, Massachusetts and Silicon Valley. Membership and delegate lists often mirror affiliations with societies such as European Respiratory Society and American Thoracic Society and feature trainees from institutions like McGill University and Monash University.
Category:Pulmonology conferences